— Know what they know.
Not Investment Advice
Also trades as: PRTC.L (LSE) · $vol 1M · PRTC (NASDAQ) · $vol 0M · PRTCY (OTC) · $vol 0M

PTCHF OTC

PureTech Health plc
1W: +0.0% 1M: -1.9% 3M: -9.4% YTD: -9.9% 1Y: -0.7% 3Y: -44.6% 5Y: -67.9%
$1.54
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 45 · $375.1M mcap · 217M float · 0.0010% daily turnover · Short 71% of daily vol

Cash Flow Trends

Operating Cash Flow
-$134M -26.9% ▼
Capital Expenditures
$11K +95.5% ▲
5Y CAGR: -75.5%
Free Cash Flow
-$134M -26.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$108M -447.4% ▼
Net Change in Cash
$90M +117.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$5M-$63M-$37M-$66M$28M
Depreciation & Amort.$7M$7M$9M$5M$4M
Stock-Based Comp.$11M$14M$15M$4M$23M
Change in Working Capital-$9M$861K$16M$18M-$10M
Other Non-Cash Items$6M-$5M-$111M-$67M-$178M
Operating Cash Flow-$132M-$158M-$179M-$106M-$134M
— Investing Activities —
Capital Expenditures-$5M-$6M-$2M-$245K-$11K
Acquisitions (Net)-$10M$321K-$20M-$14M-$106M
Investment Purchases-$1M-$500K-$269M-$196M-$310M
Investment Sales$381M$218M$184M$278M$656M
Other Investing$350K-$15M$416K$865K$255K
Investing Cash Flow$364M$197M-$107M$69M$241M
— Financing Activities —
Net Debt Issuance$40M$2M$393K-$3M-$3M
Stock Repurchased$0$0-$26M-$20M-$108M
Dividends Paid$0$0$0$0$0
Other Financing-$3M$34M-$4M$100M$93M
Financing Cash Flow$39M$23M-$30M$78M-$17M
Net Change in Cash$272M$62M-$316M$41M$90M
Cash End of Period$404M$466M$150M$191M$281M
Free Cash Flow-$137M-$164M-$181M-$106M-$134M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms